ResearchAlnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study
ResearchThe Evolution of Chimeric Antigen Receptor T-Cell, Bispecific Antibodies and Antibody-Drug Conjugates for the Treatment of Multiple Myeloma
ResearchProteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effects
ResearchEfficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS
ResearchImmune-aging is linked to clinical malignancy, racial ancestry, and vaccine responses in myeloma
ResearchStem Cell Mobilization Yields with Daratumumab and Lenalidomide-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma: A Real-World Experience at 2 Institutes
ResearchFeasibility and Safety of Outpatient Model for Administration of Bispecific Antibodies: Proceedings from an International Myeloma Society 21st Annual Meeting Oral Abstract
ResearchEarly CD4+ T cell proliferation and chronic T cell engagement impact myeloma outcomes following T cell engager therapy
ResearchInfection risk in 158 patients with relapsed/refractory multiple myeloma treated with bispecific antibodies: a single-center experience
ResearchQuadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumumab with RVD (DRVd) in transplant-eligible patients
ResearchDivergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity
ResearchEvaluating the Impacts of CYP3A4*1B and CYP3A5*3 Variations on Pharmacokinetic Behavior and Clinical Outcomes in Multiple Myeloma Patients With Autologous Stem Cell Transplant
ResearchImpaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections